A COVID-19 vaccine being developed by the University of Oxford and British pharmaceutical company AstraZeneca was found to have an average efficacy rate of 70 percent following a large-scale trial.
Keep ReadingYou might be interested in
Pfizer and BioNTech say their vaccine is ‘95% effective’ and has passed safety checks.
Keep ReadingYou might be interested in
